Stockscreener 앱 받기
6.74
8.30%
-0.61
시간 외 거래:
6.74
Rxsight Inc 주식(RXST)의 최신 뉴스
RxSight (NASDAQ: RXST) details CFO sign-on bonus and corrects option vesting - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - ACCESS Newswire
Breakout Watch: What is RxSight Incs revenue forecast2026 Opening Moves & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Aug Intraday: What is RxSight Incs revenue forecast2026 Biggest Moves & Entry Point Strategy Guides - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
RXST Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tech Rally: Is CNTY affected by consumer sentiment2026 Geopolitical Influence & Advanced Technical Signal Analysis - baoquankhu1.vn
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
US Stocks Recap: What are the risks of holding RF Acquisition Corp IIPortfolio Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Meridiem Capital Partners LP Buys New Position in RxSight, Inc. $RXST - MarketBeat
RxSight Inc Stock (ISIN: US78419L1008) Faces Analyst Pressure After Q4 Revenue Drop - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and RxSight (RXST) - The Globe and Mail
(RXST) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Stifel cuts RxSight stock price target to $9 on revenue guidance - Investing.com South Africa
Stifel Lowers Price Target for RxSight (RXST) Following Recent A - GuruFocus
Stifel Nicolaus Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price - MarketBeat
RxSight Inc. (RXST) PT Lowered to $9 at Stifel After Prudent Guidance - StreetInsider
RxSight Earnings Call: Strong Core, Cautious Outlook - TipRanks
RxSight downgraded at UBS after Q1 miss and guidance cut - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX) - The Globe and Mail
Wells Fargo Upgrades RxSight (RXST) - MSN
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Change - Yahoo Finance
RxSight announces executive leadership reorganization and new appointments - MSN
Midday Stock Roundup: Staar Falls 3.8% After Q4 Miss - Orange County Business Journal
Forecast Cut: Will RxSight Inc stock go up in YEARJuly 2025 Outlook & High Return Stock Watch Alerts - baoquankhu1.vn
RxSight (RXST) Q4 2025 Earnings Call Transcript - AOL.com
RxSight (RXST) CCO gains 6,261 shares, withholds 2,580 for taxes - Stock Titan
2026-03-03 | RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
RXST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Interest in RxSight, Inc. (NASDAQ:RXST) Expands By 29.3% - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2026-03-01 | Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation | NDAQ:RXST | Press Release - Stockhouse
Artisan Partners Limited Partnership Cuts Position in RxSight, Inc. $RXST - MarketBeat
RXST Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
RxSight, Inc. (RXST) Investor Outlook: Exploring a 28% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
RxSight, Inc. (NASDAQ:RXST) Q4 2025 Earnings Call Transcript - Insider Monkey
RXSTRxsight, Inc. Latest Stock News & Market Updates - Stock Titan
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), BioLife Solutions (BLFS) and RxSight (RXST) - The Globe and Mail
RxSight Reports Fourth Quarter and Fiscal Year Financial Results - VisionMonday.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Responsive Playbooks and the RXST Inflection - Stock Traders Daily
Needham reiterates Buy on RxSight stock, keeps $13 target By Investing.com - Investing.com Australia
RxSight (RXST) Loss Deepens In Q4 Results Reinforcing Bearish Profitability Narratives - simplywall.st
What 5 Analyst Ratings Have To Say About RxSight - Benzinga
UBS Increases Price Target for RXST to $9.00 While Maintaining N - GuruFocus
RxSight (NASDAQ:RXST) Given New $9.00 Price Target at UBS Group - MarketBeat
RXST: Piper Sandler Lowers Price Target to $10.00, Maintains Neu - GuruFocus
RxSight (NASDAQ:RXST) Price Target Lowered to $10.00 at Piper Sandler - MarketBeat
UBS Adjusts Price Target on RxSight to $9 From $8, Maintains Neutral Rating - marketscreener.com
RxSight, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Needham Reiterates Buy Rating on RxSight Inc. (RXST) - StreetInsider
RxSight Q4 Earnings Call Highlights - MarketBeat
RxSight (NASDAQ:RXST) Issues Earnings Results - MarketBeat
RxSight, Inc. (RXST) Posts Fourth Quarter Loss, Surpasses Revenue Expectations - Bitget
Earnings call transcript: RxSight Q4 2025 beats EPS, revenue forecasts - Investing.com
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: RxSight Q4 2025 beats EPS, revenue forecasts By Investing.com - Investing.com Australia
RXSIGHT INC (NASDAQ:RXST) Reports Q4 Beat but Cautious 2026 Outlook Weighs on Shares - ChartMill
0.85%
1.86%
자본화:
|
볼륨(24시간):